Several other analysts also recently commented on the company. Pi Financial restated a top pick rating on shares of Canopy Growth in a research note on Thursday, April 5th. Eight Capital raised their price target on shares of Canopy Growth from C$40.00 to C$50.00 in a research report on Friday, July 6th. Finally, Cormark raised their price target on shares of Canopy Growth from C$25.00 to C$33.00 in a research report on Thursday, June 28th.
Shares of WEED traded up C$0.71 during trading hours on Wednesday, hitting C$39.65. The stock had a trading volume of 1,140,709 shares, compared to its average volume of 5,914,108. Canopy Growth has a 1-year low of C$7.82 and a 1-year high of C$48.72.
Canopy Growth Corporation, through its subsidiaries, produces and sells medical marijuana in Canada. The company offers dried, oil, and softgel cannabis products. Canopy Growth Corporation also sells its products through online. The company was formerly known as Tweed Marijuana Inc and changed its name to Canopy Growth Corporation in September 2015.
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.